Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 31, 2021 - Issue 12
Submit an article Journal homepage
1,274
Views
7
CrossRef citations to date
0
Altmetric
Review

The patent maze of COVID 19 vaccines

Ulrich StorzMichalski · Hüttermann & Partner Patentanwälte mbB, Duesseldorf, GermanyCorrespondence[email protected]
View further author information
Pages 1177-1188 | Received 08 May 2021, Accepted 16 Jun 2021, Published online: 26 Jul 2021

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Tzu-Fu Yeh, Chen Lin & Huang-Chih Sung. (2023) A review of technological developments in lipid nanoparticle application for mRNA vaccination. Human Vaccines & Immunotherapeutics 19:2.
Read now

Articles from other publishers (6)

Daniel Mieres-Castro & Freddy Mora-Poblete. (2023) Saponins: Research Progress and Their Potential Role in the Post-COVID-19 Pandemic Era. Pharmaceutics 15:2, pages 348.
Crossref
Shiqi Huang, Yining Zhu, Ling Zhang & Zhirong Zhang. (2022) Recent Advances in Delivery Systems for Genetic and Other Novel Vaccines. Advanced Materials 34:46.
Crossref
Ling Jin. (2022) Alternative Protection of Intellectual Property Rights in Vaccine Production and Use under Covid-19. Journal of Education, Humanities and Social Sciences 1, pages 147-153.
Crossref
Ulrich Storz. (2022) The COVID-19 vaccine patent race. Nature Biotechnology 40:7, pages 1001-1004.
Crossref
Shiyu Yan. 2022. Proceedings of the 2022 6th International Seminar on Education, Management and Social Sciences (ISEMSS 2022). Proceedings of the 2022 6th International Seminar on Education, Management and Social Sciences (ISEMSS 2022) 1053 1062 .
Matteo Nioi & Pietro Emanuele Napoli. (2021) The Waiver of Patent Protections for COVID-19 Vaccines During the Ongoing Pandemic and the Conspiracy Theories: Lights and Shadows of an Issue on the Ground. Frontiers in Medicine 8.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.